8NN.F Nordic Nanovector ASA

Healthcare Biotechnology Frankfurt Exchange
0.4000 EUR
Close of Nov 12, 2026
0.2945 0.6480
Market cap
EUR 169M
P/E
-
P/B
4.13x
ROE
-12.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 8NN.F undervalued?

Graham number

The Graham number of Nordic Nanovector ASA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nordic Nanovector ASA fundamental analysis

No fundamental analysis for Nordic Nanovector ASA yet.

Nordic Nanovector ASA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nordic Nanovector ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.

Full company profile